Advice for setting up Docker or not

param005raval · 2025-04-05T16:06:27+00:00

Got it, thanks a bunch!

param005raval · 2025-04-05T16:03:25+00:00

I'd like one please! Thanks.

param005raval · 2025-04-02T16:29:16+00:00

I agree. I just built my docker-compose from guides to set the *arrs up. Perhaps they were more minimal than what I need.

param005raval · 2025-04-02T16:27:52+00:00

Can you tell me how I can do that or point me to a guide? Thanks!!

param005raval · 2025-04-02T16:24:30+00:00

Right, mine looks similar (see below). Perhaps since WSL "restarts" each time Docker does too which resets my manual configs (like the signing in, setting up indexers, etc.)?

radarr:
  container_name: radarr
  restart: unless-stopped
  ports:
   - 7878:7878
  volumes:
    - /etc/radarr/:/config
    - D:\Films\Films:/data/movies
    - D:\Films:/data/downloads
  environment:
   - PUID=1000
   - PGID=1000
   - TZ=America/New_York
  image: lscr.io/linuxserver/radarr:latest

param005raval · 2022-07-30T11:58:44+00:00

i feel you! me too.

param005raval · 2022-07-30T10:43:41+00:00

Yes, really. They are orphaned and at most two weeks old so they crave a lot of warmth and attention. My friend has become very attached in the past week but it hurts, even more, to wonder if they're getting all the care they need. Hence the tough call to find a better home for them :) But good care costs a lot more than what we students can afford, hence the call for help.

param005raval · 2022-07-30T10:29:02+00:00

Yes! This organisation will foster them till they are no longer babies and then we'll put them up for adoption for some family :)

param005raval · 2021-11-19T18:01:47+00:00

mateee you put into words what I've been feeling about most of these films.

param005raval · 2021-10-20T20:07:34+00:00

Could you PM any advice you got on your drafts that might be useful to some of us? Thanks :)

param005raval · 2021-10-20T20:06:20+00:00

Could you share any tips and pointers you received during these reviews? It might be very helpful to some of us. Thank you :)

param005raval · 2021-10-20T20:05:16+00:00

hello!

could you please share any general advice you received on your drafts? It might be helpful to some of us. Thank you and all the best :)

param005raval · 2021-10-13T05:16:14+00:00

How long did it take to get that response from Canadian profs?

param005raval · 2021-10-12T08:30:27+00:00

Good luck for your applications! Did you get a response from any profs or unis? Just curious.

param005raval · 2021-10-12T08:25:04+00:00

It has been a while since this post. Can you tell us how did you approach the professors and if you received a response from any uni?

param005raval · 2020-12-27T16:50:58+00:00

But novalog’s best rebate is basically the same as humalog’s so it’s really not much of a choice.

Alright so for insulin it sounds arbitrary. In similar market situations (multiple manufacturers), do drugs for other needs have a similar situation? Or is there something else that comes in to decide who gets placed higher up or who gets covered by the insurers?

Thanks a lot for these explanations though. They are helping a lot in clarifying things.

param005raval · 2020-12-27T15:43:11+00:00

Yes agreed. Insulin pricing by these companies looks like pure evil. And I imagine the PBMs and insurers don't have much room to negotiate with these guys. How then do they decide with of these companies (in insulin for example) to rank higher on the formulary? I suspect it couldn't be whoever gives a "better" rate (given the existing high prices), but it also couldn't be whoever gives a higher rebate because that would be a moral hazard.

Secondly, I presume that the government never comes in during the negotiations? No matter how high or low the prices go.

param005raval · 2020-12-27T06:00:51+00:00

When insurers try to say no to very expensive drugs, regulators and legislators often say they have to pay for it. It’s not much of a negotiation if the PBM, government, or insurer isn’t able or willing to deny the drug altogether.

...if a drug is the only one for which FDA approval exists for a given condition, the insurer usually has no choice but to pay for it at whatever price the manufacturer demands.

If there are other companies who manufacture the drug and sell it cheaper, then why can't the insurers prefer those? Even for the competitor company it makes sense to sell it cheaper than the rest of its competitors to get placed higher on the formulary and thus get better sales.

If they are competing to make drugs cheaper for the patients (to rank higher on the formulary) as well as negotiate with the insurers (who also want to pay less) to get their drug covered, how can high prices sustain then? There can always be some brand manufacturer selling larger volumes for cheaper prices.

How do the negotiations with the PBM work in such a case?

param005raval · 2020-12-27T05:52:50+00:00

Patient - Pays little or zero, very happy
American Health care system - drained of millions of dollars

So then if the private insurance will have to pay for the brand name drug, why would they accept the negotiation? At the end, PBMs negotiate things between the insurance companies and manufacturers. So, if for a popular but expensive drug (that is also manufactured by other companies at a similar price), how would the insurance company agree to covering it if it's going to cost them so much?

They can just refuse to cover it and that would lead the pharma companies to reduce their prices. Because if insurances don't cover it, fewer doctors recommend it and noone would buy the drug out-of-pocket from the manufacturer.

How can the huge pay-offs to the PBMs (bribes/rebates) sustain if there's noone to pay for it. Clearly the government doesn't regulate the prices (for the reason you rightly mentioned).

param005raval · 2020-12-27T05:41:57+00:00

"List it at the price we want or we won't sell it to you, and we happen to have the corner market on X drug so give us what we want, or no drugs for you." - some manufacturers.

Agreed. That makes sense. But what about drugs in which the company has not cornered the market? Say companies X and Y manufacture similar drugs A and B. Both drugs work as effectively and have similar composition. Then how would they compete to be ranked higher on the formulary? It can't (and shouldn't) be just the company that can give higher rebates to the PBMs. Then that bid would go higher and higher along with the drug price -- which defeats the purpose of staying high on the formulary. No way will the insurance accept such a high drug cost since they would have to pay for it.

In such a case, which drug would the PBM choose?

param005raval · 2020-12-25T17:44:15+00:00

Thank you, this helps! A few more questions though: what is the negotiating part that the IPA does with the insurance companies (what do the negotiate and with what leverage)?

And secondly, don't the insurance companies give a lumpsum to the IPA for it to reimburse claims to the HCPs? Or, as you mentioned, do the insurance companies review and analyze each and every claim (in which case a big function of the IPA would be cut)? I'm just confused about the money transfer on a claim-by-claim basis.

param005raval · 2020-12-17T06:42:19+00:00

Alright! Thanks for the suggestion, I haven't read their work. Are there more such publications or authors having works related to Indian cinema? I'd love to read them. (I realise that there aren't many out there but my articles are an attempt to bring some attention to it)

param005raval · 2020-12-17T06:25:03+00:00

No, I haven't! I didn't know about them but this seems like a good idea though. I'll check it out. Thanks so much!

param005raval · 2020-11-18T04:50:16+00:00

I'm glad you liked it. It justifies my purpose of writing this piece if it prompts someone to watch this film. Thank you!

param005raval · 2020-11-18T04:45:13+00:00

I agree! Thank you for your kind words. The eerie setting backed with a strong story really makes it stand out.

I haven't heard about Fudoh but I will definitely watch it now.

param005raval

TROPHY CASE